Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024
Operating activities:
Net loss	$ (29,327)	$ (48,697)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	5,399	6,300
Goodwill impairment	11,052	23,989
Non-cash lease expense	13	(304)
Change in fair value of warrant liabilities	(179)	(372)
Amortization of debt discount and financing issuance costs	239	0
Stock based compensation	3,609	4,503
Gain on sale of ViewSpot, net	(1,287)	0
Deferred income taxes	(128)	(40)
Gain on license of patents, net	0	(198)
Changes in operating accounts:
Accounts receivable	3,905	2,191
Prepaid expenses and other assets	247	361
Accounts payable, accrued, and other liabilities	(736)	(2,028)
Net cash used in operating activities	(7,193)	(14,295)
Investing activities:
Capital expenditures, net	(88)	(20)
Proceeds from sale of ViewSpot, net	1,287	0
Proceeds from license of patents, net	0	198
Net cash provided by investing activities	1,199	178
Financing activities:
Issuance of Common Stock and warrants in connection with common stock offering, net of issuance costs	3,352	9,839
Issuance of Notes payable and warrants	1,333	0
Proceeds from financing arrangements	933	1,043
Repayments of financing arrangements	(940)	(1,087)
Other financing activities	2	5
Net cash provided by financing activities	4,680	9,800
Net decrease in cash and cash equivalents	(1,314)	(4,317)
Cash and cash equivalents, beginning of period	2,808	7,125
Cash and cash equivalents, end of period	1,494	2,808
Supplemental disclosure of non-cash financing activities:
Deemed dividend	$ 769	$ 0